ForSight Labs is a biotechnology and healthcare startup founded in 2005, with a clear mission encapsulated in their slogan: "Innovative solutions enhancing vision and quality of life for visually impaired patients through collaboration and advanced technology." The company is dedicated to creating and implementing solutions that enhance the vision, care, and quality of life for visually impaired individuals, operating within high-impact eye care companies. Every day, countless individuals depend on their vision and endure significant hardships when it is compromised. Vision loss drastically affects the quality of life, making it one of the most impactful disabilities. In the US, the number of people experiencing vision impairment, including blindness, is projected to more than double in the next three decades, with the annual cost of vision loss in the US recently estimated to exceed $50 billion. ForSight Labs unites highly driven and capable team members, clinicians, and investors with a shared focus on initiating and sustaining efforts to provide innovative solutions to the ophthalmic community and the patients it serves. Last investment: $1.70M Debt Financing investment at 04 September 2015. The investors for this round are not specified. In summary, ForSight Labs is a forward-thinking startup addressing a substantial need in the healthcare and biotechnology industries through innovative and impactful solutions for visually impaired patients. With a clear focus and a track record of attracting significant investments, ForSight Labs demonstrates potential for growth and impact in the coming years.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $1.70M | - | 04 Sep 2015 | |
Venture Round | $3.00M | - | 08 Dec 2014 | |
Venture Round | $1.00M | - | 06 May 2014 | |
Series C | $15.00M | 4 | 16 Apr 2014 | |
Series B | $9.30M | 4 | 17 Jun 2013 |
No recent news or press coverage available for ForSight Labs.